Citadel Advisors - BIOLINERX LTD ownership

BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 28 filers reported holding BIOLINERX LTD in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BIOLINERX LTD
ValueSharesWeighting
Q3 2023$295,302
-28.1%
162,254
-37.0%
0.00%
Q2 2023$410,983
+878.5%
257,669
+679.1%
0.00%
Q2 2022$42,000
+121.1%
33,074
+200.7%
0.00%
Q1 2022$19,000
-79.1%
11,000
-75.4%
0.00%
Q4 2021$91,000
-86.6%
44,800
-81.9%
0.00%
Q3 2021$677,000
+129.5%
247,750
+136.0%
0.00%
Q2 2021$295,000
+137.9%
104,997
+113.0%
0.00%
Q4 2020$124,00049,3010.00%
Other shareholders
BIOLINERX LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Parkman Healthcare Partners LLC 270,665$463,0000.14%
ACT CAPITAL MANAGEMENT, LLC 27,500$47,0000.05%
Cutter & CO Brokerage, Inc. 18,667$32,0000.01%
Opaleye Management Inc. 16,667$29,0000.01%
Apollon Wealth Management, LLC 56,410$96,0000.01%
Sandy Cove Advisors, LLC 3,597$6,0000.01%
Atria Wealth Solutions, Inc. 104,032$178,0000.00%
Thomasville National Bank 10,000$17,0000.00%
Geneos Wealth Management Inc. 32,950$56,0000.00%
GROUP ONE TRADING, L.P. 9,923$17,0000.00%
View complete list of BIOLINERX LTD shareholders